Description of clinical and genetic features of 122 patients included in the Spanish Pompe registry

Rafael Jenaro Martinez-Marin,David Reyes-Leiva,Andres Nascimento,Nuria Muelas, C. Dominguez-Gonzalez,Carmen Paradas,Montse Olive,Mar Garcia-Romero,Samuel Ignacio Pascual-Pascual,Josep Maria Grau,Miguel Angel Barba-Romero,Maria Teresa Gomez-Caravaca,Javier de las Heras, Pilar Casquero,Maria Dolores Mendoza, Juan Carlos de Leon, Antonio Gutierrez,German Moris, Raquel Blanco-Lago,Alba Ramos-Fransi, Guillem Pintos, Maria Jose Garcia-Antelo, Maria Rabasa,Yolanda Morgado,Mercedes Uson, Francisco Javier Miralles, Jose Eulalio Barcena-Llona, Ana Belen Gomez-Belda, Maria Isabel Pedraza-Hueso, Miryam Hortelano, Antoni Colome, Guillermina Garcia-Martin,Adolfo Lopez de Munain,Ivonne Jerico, Lucia Galan-Davila,Julio Pardo, Giorgina Salgueiro-Origlia,Jorge Alonso-Perez,Francesc Pla-Junca, Marianela Schiava, Sonia Segovia-Simon,Jordi Diaz-Manera

NEUROMUSCULAR DISORDERS(2024)

引用 0|浏览15
暂无评分
摘要
Pompe disease is a rare genetic disorder with an estimated prevalence of 1:60.0 0 0. The two main phenotypes are Infantile Onset Pompe Disease (IOPD) and Late Onset Pompe Disease (LOPD). There is no published data from Spain regarding the existing number of cases, regional distribution, clinical features or, access and response to the treatment. We created a registry to collect all these data from patients with Pompe in Spain. Here, we report the data of the 122 patients registered including nine IOPD and 113 LOPD patients. There was a high variability in how the diagnosis was obtained and how the follow-up was performed among different centres. Seven IOPD patients were still alive being all treated with enzymatic replacement therapy (ERT) at last visit. Ninety four of the 113 LOPD patients had muscle weakness of which 81 were receiving ERT. We observed a progressive decline in the results of muscle function tests during follow-up. Overall, the Spanish Pompe Registry is a valuable resource for understanding the demographics, patient's journey and clinical characteristics of patients in Spain. Our data supports the development of agreed guidelines to ensure that the care provided to the patients is standardized across the country.(c) 2023 Published by Elsevier B.V.
更多
查看译文
关键词
Pompe disease,Glycogen storage disease type II,Patient registry,Spanish Pompe registry,Acid maltase deficiency,Myozime,Enzymatic replacement therapy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要